LV12375A - 1-(3-aminoindazol-5-il)-fenilmetil)-cikliskas urinvielas piemerotas ka HIV proteazes inhibitori - Google Patents

1-(3-aminoindazol-5-il)-fenilmetil)-cikliskas urinvielas piemerotas ka HIV proteazes inhibitori

Info

Publication number
LV12375A
LV12375A LV990076A LV990076A LV12375A LV 12375 A LV12375 A LV 12375A LV 990076 A LV990076 A LV 990076A LV 990076 A LV990076 A LV 990076A LV 12375 A LV12375 A LV 12375A
Authority
LV
Latvia
Prior art keywords
hiv protease
aminoindazol
phenylmethyl
protease inhibitors
compounds
Prior art date
Application number
LV990076A
Other languages
English (en)
Other versions
LV12375B (lv
Inventor
James David Rodgers
Robert Frank Kaltenbach Iii
Original Assignee
Du Pont Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Pharm Co filed Critical Du Pont Pharm Co
Publication of LV12375A publication Critical patent/LV12375A/lv
Publication of LV12375B publication Critical patent/LV12375B/lv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
LVP-99-76A 1996-11-08 1999-04-29 1-(3-aminoindazol-5-il)-fenilmetil)-cikliskas urīnvielas piemērotas kā hiv proteāzes inhibitori LV12375B (lv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74710496A 1996-11-08 1996-11-08
US2974596P 1996-11-08 1996-11-08
PCT/US1997/020035 WO1998020008A1 (en) 1996-11-08 1997-11-04 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as hiv protease inhibitors

Publications (2)

Publication Number Publication Date
LV12375A true LV12375A (lv) 1999-11-20
LV12375B LV12375B (lv) 2000-04-20

Family

ID=26705293

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-99-76A LV12375B (lv) 1996-11-08 1999-04-29 1-(3-aminoindazol-5-il)-fenilmetil)-cikliskas urīnvielas piemērotas kā hiv proteāzes inhibitori

Country Status (21)

Country Link
EP (1) EP0937067B1 (lv)
JP (1) JP2001503428A (lv)
KR (1) KR20000053122A (lv)
CN (1) CN1235602A (lv)
AT (1) ATE244714T1 (lv)
AU (1) AU5165198A (lv)
BR (1) BR9712910A (lv)
CA (1) CA2270966A1 (lv)
CZ (1) CZ157599A3 (lv)
DE (1) DE69723456T2 (lv)
EA (1) EA199900452A1 (lv)
EE (1) EE9900188A (lv)
ES (1) ES2202645T3 (lv)
HU (1) HUP9904676A2 (lv)
IL (1) IL129727A0 (lv)
LV (1) LV12375B (lv)
NO (1) NO992228L (lv)
PL (1) PL333421A1 (lv)
SI (1) SI20074A (lv)
SK (1) SK59699A3 (lv)
WO (1) WO1998020008A1 (lv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6870098A (en) * 1997-03-31 1998-10-22 Du Pont Merck Pharmaceutical Company, The Indazoles of cyclic ureas useful as hiv protease inhibitors
US7135575B2 (en) 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
AU2007210073B2 (en) 2006-01-31 2011-10-06 Array Biopharma Inc. Kinase inhibitors and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610294A (en) * 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
US5532357A (en) * 1995-06-07 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas

Also Published As

Publication number Publication date
CZ157599A3 (cs) 1999-11-17
EE9900188A (et) 1999-12-15
WO1998020008A1 (en) 1998-05-14
BR9712910A (pt) 2000-03-21
DE69723456T2 (de) 2004-05-27
KR20000053122A (ko) 2000-08-25
PL333421A1 (en) 1999-12-06
IL129727A0 (en) 2000-02-29
NO992228D0 (no) 1999-05-07
JP2001503428A (ja) 2001-03-13
ATE244714T1 (de) 2003-07-15
NO992228L (no) 1999-06-07
SK59699A3 (en) 1999-12-10
AU5165198A (en) 1998-05-29
SI20074A (sl) 2000-04-30
ES2202645T3 (es) 2004-04-01
EP0937067B1 (en) 2003-07-09
LV12375B (lv) 2000-04-20
CA2270966A1 (en) 1998-05-14
CN1235602A (zh) 1999-11-17
HUP9904676A2 (hu) 2000-06-28
DE69723456D1 (de) 2003-08-14
EP0937067A1 (en) 1999-08-25
EA199900452A1 (ru) 2000-02-28

Similar Documents

Publication Publication Date Title
BR9911488A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto
EA200100411A1 (ru) Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
EA200000298A1 (ru) Агонисты простагландинов и их применение для лечения заболеваний костей
EA200100412A1 (ru) Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
BR9914221B1 (pt) Derivados de glicopeptídeos e composições farmacêuticas contendo os mesmos
BR9908004A (pt) Composto, composição e método para prevençãoou supressão de uma infecção viral
ES2171723T3 (es) 3,4-diaril-2-hidroxi-2,5-dihidrofuranos como profarmacos de inhibidores de cox-2.
BR0305258A (pt) Inibidores de polimerase de ns5b de hcv
EA200000759A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
EA200200471A1 (ru) Конденсированные нафтиридины в качестве ингибиторов обратной транскриптазы вич
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
ES2243579T3 (es) Derivados de pirazolopirideno.
BR9916004A (pt) Inibidores de proteinase c de pró-colágeno
BR9610527A (pt) Novos derivados de substâncias de ciclodepsipeptìdeo pf1022
ES2151600T3 (es) Derivados de n-(3-amino-2-hidroxibutil)sulfonamida utilizados como inhibidores de proteasa de vih.
YU62504A (sh) Triciklična 2-pirimidonska jedinjenja korisna kao inhibitori hiv reverzne transkriptoze
BR9813719A (pt) Agentes terapêuticos
ATE223376T1 (de) Bisarylcyclobutenderivate als cyclooxygenasehemmer
ES2147973T3 (es) Estirenos alquilatados como profarmacos de inhibidores de cox-2.
EA200100711A1 (ru) Аналоги нуклеозида (варианты) и их применение, комбинация и способ лечения вирусных инфекций, фармацевтическая композиция
NO983511D0 (no) Difenylstilbener som pro-legemidler for COX-2-inhibitorer
TR200003065T2 (tr) Nöraminidazların inhibitörleri olarak pirolidinler.
SE9904128D0 (sv) Novel compounds
LT2003003A (en) Tricyclic 2-pyridone compounds useful as hiv reverse transcriptase inhibitors
EA200600560A1 (ru) Ингибиторы проникновения вируса вич